These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 15194006

  • 1. Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells.
    Niederberger E, Manderscheid C, Grösch S, Schmidt H, Ehnert C, Geisslinger G.
    Biochem Pharmacol; 2004 Jul 15; 68(2):341-50. PubMed ID: 15194006
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.
    Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S, Kennedy B, Leblanc Y, Leger S, Mancini J, O'Neill GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasit P, Rodger I.
    J Pharmacol Exp Ther; 1999 Aug 15; 290(2):551-60. PubMed ID: 10411562
    [Abstract] [Full Text] [Related]

  • 7. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells.
    Maier TJ, Schilling K, Schmidt R, Geisslinger G, Grösch S.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1469-78. PubMed ID: 15041464
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.
    Waskewich C, Blumenthal RD, Li H, Stein R, Goldenberg DM, Burton J.
    Cancer Res; 2002 Apr 01; 62(7):2029-33. PubMed ID: 11929821
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL.
    Cancer Res; 2002 Feb 01; 62(3):625-31. PubMed ID: 11830509
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines.
    Buecher B, Bouancheau D, Broquet A, Bezieau S, Denis MG, Bonnet C, Heymann MF, Jarry A, Galmiche JP, Blottière HM.
    Anticancer Res; 2005 Feb 01; 25(1A):225-33. PubMed ID: 15816542
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro.
    Mohseni H, Zaslau S, McFadden D, Riggs DR, Jackson BJ, Kandzari S.
    J Surg Res; 2004 Jun 15; 119(2):138-42. PubMed ID: 15145695
    [Abstract] [Full Text] [Related]

  • 19. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation.
    Haider A, Lee I, Grabarek J, Darzynkiewicz Z, Ferreri NR.
    Circulation; 2003 Aug 26; 108(8):1015-21. PubMed ID: 12912810
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation.
    Steffel J, Hermann M, Greutert H, Gay S, Lüscher TF, Ruschitzka F, Tanner FC.
    Circulation; 2005 Apr 05; 111(13):1685-9. PubMed ID: 15795326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.